Navigation Links
Pancreatic Cancer Biomarkers Found
Date:6/13/2008

Blood test for 5 proteins could detect disease sooner, when it's more treatable

FRIDAY, June 13 (HealthDay News) -- Five proteins linked to early development of pancreatic cancer have been identified by U.S. researchers, who said the finding is a step forward in efforts to develop a blood test to detect this type of cancer in the early stages, when cure rates are highest.

"Our team identified, for the first time, protein changes associated with early-stage pancreatic tumor development in genetically engineered mice that were also found to be associated with the presence of disease in humans at an early, pre-symptomatic stage," senior author Dr. Samir Hanash, of the Fred Hutchinson Cancer Research Center in Seattle, said in a prepared statement.

They first identified the five proteins in mice with a precancerous condition called pancreatic intraepithelial neoplasma. The condition, if left untreated, eventually progresses to full-blown pancreatic cancer. The researchers then looked for the same proteins in blood samples from 13 people with asymptomatic, early-stage pancreatic cancer.

The study was published in this week's issue of the online journal PLoS Medicine.

If this five-biomarker panel can be developed into a commercial screening test, it may prove particularly useful when combined with a currently available test that measures levels of a pancreatic cancer biomarker called CA19.9. Eighty percent of newly diagnosed pancreatic cancer patients have elevated levels of CA19.9, which is not linked to early-stage disease with symptoms.

The researchers suggested that combined use of the five-biomarker panel and the CA19.9 test may greatly improve detection of early-stage pancreatic cancer before the onset of symptoms and may also help distinguish between cancer and pancreatitis, a noncancerous, inflammatory condition.

Pancreatic cancer is the fourth leading cause of cancer death in the United States. It has a five-year survival rate of only 3 percent. Because there are no symptoms in the early stages, most patients aren't diagnosed until the cancer has spread beyond the pancreas. This is a major reason for the poor long-term survival rates.

More information

The American Cancer Society has more about pancreatic cancer.



-- Robert Preidt



SOURCE: Fred Hutchinson Cancer Research Center, news release, June 9, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New treatment combination safe for pancreatic cancer patients
2. 3-Drug Combo Improves Advanced Pancreatic Cancer Outcomes
3. Beer Drinking May Speed Pancreatic Cancer Onset
4. Traditional herbal medicine kills pancreatic cancer cells, Jefferson researchers report
5. The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding
6. Calorie restricted diet prevents pancreatic inflammation and cancer
7. Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find
8. Jefferson scientists discovery may help explain smoking-pancreatic cancer link
9. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
10. Patrick Swayzes Diagnosis With Pancreatic Cancer: a Statement From the Pancreatic Cancer Action Network
11. Treatment Combo for Pancreatic Cancer Has Limited Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... For many artists, the act of blending paint ... it into a science. , Using the new, highly precise METTLER TOLEDO ML204T ... add depth and meaning to his works. What’s more, it has allowed him to ...
(Date:5/2/2016)... ... May 02, 2016 , ... The debilitating disease of arthritis can bring patients ... most patients must deal with prescription costs to treat arthritis over the course of ... savings at the pharmacy on many common prescriptions. , Arthritis , Although arthritis is ...
(Date:5/2/2016)... ... May 02, 2016 , ... Summit BHC (Summit), a ... of Twin Lakes Recovery Center. Located east of Atlanta in Monroe, Georgia, ... The residential facility is set on 34 acres of beautiful, secluded property that ...
(Date:5/2/2016)... ... May 02, 2016 , ... Marshall Votta, Josh Holmes and Laura ... development roles to drive RowdMap Inc.’s market growth across both health plans and provider ... order to succeed in value based care. , Marshall Votta joins RowdMap, Inc. as ...
(Date:5/1/2016)... , ... May 02, 2016 , ... ... for original 1968 Jimi Hendrix Merriweather Post Pavilion in Columbia, Maryland concert posters. ... concert poster. The concert was held on August 16. According to Hawley, “The ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
Breaking Medicine Technology: